BIFIDOBACTERIUM LONGUM ABLE TO BENEFICIALLY MODULATE IMMUNE RESPONSE TO RESPIRATORY VIRUS INFECTION

• Main Authors: HESSEL EDITH M, GROEGER DAVID, O'MAHONY LIAM, KIELY BARRY, GRANT RAYMOND ALAN, MICHALOVICH DAVID, WILLIAMSON RICHARD A
• Format: Patent
• Language: Chinese; English
• Published: 29.10.2019
• Subjects: BEER; BIOCHEMISTRY; CHEMISTRY; COMPOSITIONS THEREOF; CULTURE MEDIA; ENZYMOLOGY; HUMAN NECESSITIES; HYGIENE; MEDICAL OR VETERINARY SCIENCE; METALLURGY; MICROBIOLOGY; MICROORGANISMS OR ENZYMES; MUTATION OR GENETIC ENGINEERING; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES; PROCESSES USING MICROORGANISMS; PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS; SPIRITS; VINEGAR; WINE

Bifidobacterium longum strains and cell wall fractions isolated from Bifidobacterium longum strains are useful in the prophylaxis or treatment of a respiratory viral infection in a subject. They are also useful in the prophylaxis of a secondary bacterial infection associated with a respiratory viral infection in a subject, especially a subject who is susceptible to respiratory infections. 长双歧杆菌菌株和分离自长双歧杆菌菌株的细胞壁组分用于预防或治疗对象的呼吸道病毒感染。它们还用于预防对象的与呼吸道病毒感染相关的继发细菌感染，尤其是对呼吸道感染易感的对象。